Skip to content

Author

Na Ta

We have 2 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Identification of glycolysis- and myocardial fibrosis-related diagnostic biomarkers in heart failure: an integrative bioinformatics and machine learning study

Heart failure (HF) is a leading cause of global morbidity and mortality, yet the crosstalk between energy metabolism reprogramming and myocardial fibrosis remains poorly understood. This study aimed to identify glycolysis- and myocardial fibrosis-related diagnostic biomarkers in HF through integrative bioinformatic...

Lin Yang, Bing Liu, Shuang Qiu et al. · 0 citations
Aug 2026

The addition of evolocumab vs ezetimibe to statin therapy for coronary plaque regression and sd-LDL reduction in patients with ultrahigh-risk ASCVD.

In patients with ultrahigh-risk ASCVD, evolocumab was more effective than ezetimibe in promoting coronary plaque regression and the importance of targeting sd-LDL to reduce residual cardiovascular risk is underscored.

Xiao-Ping Li, Lin Yang, X. Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.